LEADER 04870nam 22006495 450 001 9910298348603321 005 20250609111834.0 010 $a1-4939-1071-X 024 7 $a10.1007/978-1-4939-1071-7 035 $a(CKB)3710000000186777 035 $a(EBL)1782066 035 $a(SSID)ssj0001295367 035 $a(PQKBManifestationID)11843689 035 $a(PQKBTitleCode)TC0001295367 035 $a(PQKBWorkID)11337062 035 $a(PQKB)11231540 035 $a(MiAaPQ)EBC1782066 035 $a(DE-He213)978-1-4939-1071-7 035 $a(PPN)179922742 035 $a(MiAaPQ)EBC6241644 035 $a(EXLCZ)993710000000186777 100 $a20140708d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aNeuroinflammation and Neurodegeneration /$fedited by Phillip K. Peterson, Michal Toborek 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014. 215 $a1 online resource (606 p.) 300 $aDescription based upon print version of record. 311 08$a1-322-13322-0 311 08$a1-4939-1070-1 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aThe Blood Brain Barrier -- Immune Cell Trafficking in the Central Nervous System -- General Physiology and Pathophysiology of Microglia Inflammation and the Pathophysiology of Astrocytes in Neurodegenerative Diseases -- Oxidative stress, neuroinflammation, and neurodegeneration -- Peripheral Neuroimmune Interactions and Neuropathic Pain -- Innate and Adaptive Immune-Mediated Neuroinflammation and Neurodegeneration in Parkinson?s Disease -- Multiple sclerosis: impact on functioning of the blood-brain barrier -- Neuroinflammation in Alzheimer?s disease -- Neuroinflammation in Huntington?s Disease -- Neuroinflammation and immune regulation in ischemic stroke: identification of new pharmacological targets -- HIV/NeuroAIDS -- Herpes Simplex Virus Infections Of The Central Nervous System -- Congenital Cytomegalovirus Disease -- Japanese Encephalitis: A Tale of Inflammation and Degeneration in the Central Nervous System -- The biology and clinical consequence of infection with the human polyomavirus JCV -- Role of Retrovirus-Induced Transactivator Proteins in Neuroinflammatory Disease -- Immunopathogenesis of bacterial meningitis -- Cerebral Malaria -- HIV and Cocaine Interplay in HIV-associated Neurocognitive Disorders -- Methamphetamine Neurotoxicity and Neuroinflammatory Processes -- Drugs of Abuse and NeuroAIDS: Opiates -- Cannabinoids -- Alcohol and Neurodegeneration -- Cell-Based Drug Delivery for Improving Antiretroviral Therapeutic Outcomes -- Immunomodulatory Therapeutics for Neurodegenerative Diseases -- Therapeutic Potential Of Cannabinoids. 330 $aState of the art reviews by experts in the fields of neuroscience, immunology, microbiology/infectious diseases, and pharmacology addressing the convergence of the immune system (neuroinflammation) and the loss of neurons (neurodegeneration).  Many of the diseases that are discussed in the book are of epidemic proportion, e.g., Alzheimer?s disease, Parkinson?s disease, stroke, viral encephalitis, and substance abuse.  In addition to discussions of the involvement of neuroinflammation and neurodegeneration in these disorders, scientific reviews are presented on the cells and mediators that participate in defense of and damage to the nervous system.   With rare exception, no or inadequate treatment exists for the diseases discussed in this book.  An underlying premise of the book is that understanding of their shared pathogenic mechanisms will lead to improved therapies. Given the rapid evolution of the field of Neuroimmune Pharmacology, readers will find this book to be the most timely and authoritative reference on the subject of each of its chapters. 606 $aNeurosciences 606 $aNeurochemistry 606 $aNeurobiology 606 $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006 606 $aNeurochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/B18010 606 $aNeurobiology$3https://scigraph.springernature.com/ontologies/product-market-codes/L25066 615 0$aNeurosciences. 615 0$aNeurochemistry. 615 0$aNeurobiology. 615 14$aNeurosciences. 615 24$aNeurochemistry. 615 24$aNeurobiology. 676 $a616.8 676 $a616.8/0471 702 $aPeterson$b Phillip K$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aToborek$b Michal$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910298348603321 996 $aNeuroinflammation and Neurodegeneration$92513135 997 $aUNINA LEADER 02139oas 22007453 450 001 9910837800103321 005 20250922213015.0 011 $a2378-7651 035 $a(OCoLC)60616551 035 $a(CONSER) 2015201166 035 $a(CKB)110978977978316 035 $a(EXLCZ)99110978977978316 100 $a20050614b19742003 uy a 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aLand use law & zoning digest 210 1$aChicago, Illinois :$cAmerican Society of Planning Officials,$d1974-[2003] 210 1$aChicago, Illinois :$cAmerican Planning Association 311 08$a0094-7598 517 1 $aLand use law and zoning digest 531 0 $aLand use law zoning dig. 606 $aZoning law$zUnited States$vPeriodicals 606 $aZoning law$zUnited States$vDigests 606 $aLand use$xLaw and legislation$zUnited States$vPeriodicals 606 $aLand use$xLaw and legislation$zUnited States$vDigests 606 $aLand use$xLaw and legislation$2fast$3(OCoLC)fst00991514 606 $aZoning law$2fast$3(OCoLC)fst01184633 607 $aUnited States$2fast 608 $aDigests.$2fast 608 $aPeriodicals.$2fast 615 0$aZoning law 615 0$aZoning law 615 0$aLand use$xLaw and legislation 615 0$aLand use$xLaw and legislation 615 7$aLand use$xLaw and legislation. 615 7$aZoning law. 676 $a346/.73/04505 676 $a346/.73/04505 712 02$aAmerican Planning Association. 712 02$aAmerican Society of Planning Officials. 801 0$bOCLCS 801 1$bOCLCS 801 2$bOCLCQ 801 2$bOCLCE 801 2$bOCLCQ 801 2$bTXA 801 2$bOCLCF 801 2$bOCLCO 801 2$bDLC 801 2$bOCLCQ 801 2$bAU@ 801 2$bOCL 801 2$bVT2 801 2$bOCLCO 801 2$bTXQ 801 2$bOCLCQ 801 2$bU3W 801 2$bOCLCL 906 $aJOURNAL 912 $a9910837800103321 996 $aLand use law & zoning digest$94131253 997 $aUNINA